Twin pregnancy and severe maternal mental illness: a Canadian population-based cohort study
Lapinsky SC, Ray JG, Brown HK, Murphy KE, Kaster TS, Vigod SN. Arch Womens Ment Health. 2023; 26(1):57-66. Epub 2023 Jan 11.
Publications
Association of physician financial incentives with primary care enrolment of adults with serious mental illnesses in Ontario: a retrospective observational population-based study
Bayoumi I, Whitehead M, Li W, Kurdyak P, Glazier RH. CMAJ Open. 2023; 11(1):E1-12. Epub 2023 Jan 10.
Young adults with intellectual and developmental disabilities who participate in Special Olympics are less likely to be diagnosed with depression
Lloyd M, Temple VA, Foley JT, Yeatman S, Lunsky Y, Huang A, Balogh R. Soc Psychiatry Psychiatr Epidemiol. 2023; 58(11):1699-708. Epub 2022 Dec 22.
The association between prior mental health service utilization and risk of recidivism among incarcerated Ontario residents
Lebenbaum M, Kouyoumdjian F, Huang A, Kurdyak P. Can J Psychiatry. 2022; Dec 14 [Epub ahead of print].
Evaluating the association between urine drug screening frequency and retention in opioid agonist treatment in Ontario, Canada: a retrospective cohort study
Morin KA, Dabous JR, Vojtesek F, Marsh D. BMJ Open. 2022; 12:e060857.
Physician healthcare visits for mental health and substance use during the COVID-19 pandemic in Ontario, Canada
Myran DT, Cantor N, Rhodes E, Pugliese M, Hensel J, Taljaard M, Talarico R, Garg AX, McArthur E, Liu C, Jeyakumar N, Simon C, McFadden T, Gerin-Lajoie C, Sood MM, Tanuseputro P. JAMA Netw Open. 2022; 5(1):e2143160. Epub 2022 Jan 21.
A retrospective cohort study comparing in-person and telemedicine-based opioid agonist treatment in Ontario, Canada, using administrative health data
Morin KA, Parrotta MD, Eibl JK, Marsh DC. Eur Addict Res. 2021; 27 (4): 268–276.
Evaluating the effectiveness of concurrent opioid agonist treatment and physician-based mental health services for patients with mental disorders in Ontario, Canada
Morin KA, Eibl JK, Caswell JM, Rush B, Mushquash C, Lightfoot NE, Marsh DC. PLoS One. 2020; 15(12): e0243317.
A cohort study evaluating the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention for patients in opioid agonist treatment (OAT) across Ontario, Canada, using administrative health data
Morin KA, Eibl JK, Gauthier G, Rush B, Mushquash C, Lightfoot NE, Marsh DC. Harm Reduct J. 2020; 17(1):51.
Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada
Morin KA, Eibl JK, Caswell JM, Gauthier G, Rush B, Mushquash C, Lightfoot NE, Marsh DC. Subst Abuse Treat Prev Policy. 2019; 14(1): 29.